Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.46 |
| ▸ | CTSC | P53634 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21495214 | 1.00 | SLC7A5 (0.59) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL288607 | 0.93 | SLC7A5 (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL28820471 | 0.93 | SLC7A5 (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL8835936 | 0.93 | SLC7A5 (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL29160724 | 0.91 | SLC7A5 (0.66) | SLC7A5ALPIPKMPTGS1XIAP | |
| Succinic Acid SCHEMBL15324180 | 0.87 | SLC15A1 (0.55) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL1526409 | 0.86 | ALPI (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL27232046 | 0.86 | ALPI (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL8609126 | 0.86 | SLC7A5 (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL9117463 | 0.85 | SLC7A5 (0.58) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | claimed |
| CN-110099576-B | Food or drink containing cycloalanylserine and ethanol and/or propylene glycol | 三得利控股株式会社 | 2023-02-28 | — | — | CN | disclosed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | disclosed |
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | disclosed |
| EP-2628802-B1 | DNA VACCINE BASED ON B7-1-PE40KDEL EXOTOXIN FUSION GENE AND USE THEREOF | AFFILIATED HOSPITAL OF ACADEMY OF MILITARY MEDICAL SCIENCES PLA (CN) | 2016-10-26 | — | — | EP | disclosed |
| CN-105307514-A | Plant extract containing diketopiperazine and method for producing same | SUNTORY HOLDINGS LTD | 2016-02-03 | — | — | CN | disclosed |
| US-9029520-B2 | B7-1-PE40KDEL exotoxin fusion gene-based DNA vaccine and the use thereof | AFFILIATED HOSPITAL OF ACADEMY OF MILITARY MEDICAL SCIENCES, PLA (CN) | 2015-05-12 | — | — | US | disclosed |
| US-20130344101-A1 | B7-1-PE40KDEL EXOTOXIN FUSION GENE-BASED DNA VACCINE AND THE USE THEREOF | AFFILIATED HOSPITAL OF ACADEMY OF MILITARY MEDICAL SCIENCES, PLA (CN) | 2013-12-26 | — | — | US | disclosed |
| EP-1809325-B1 | VACCINES AGAINST JAPANESE ENCEPHALITIS VIRUS | SANOFI PASTEUR BIOLOGICS LLC (US) | 2013-11-20 | — | — | EP | disclosed |
| EP-2628802-A1 | DNA VACCINE BASED ON B7-1-PE40KDEL EXOTOXIN FUSION GENE AND USE THEREOF | Affiliated Hospital of Academy of Military Medical Sciences, PLA (CN) | 2013-08-21 | — | — | EP | disclosed |
| US-8029802-B2 | Vaccines against Japanese encephalitis virus and West Nile virus | SANOFI PASTEUR BIOLOGICS CO. (US) | 2011-10-04 | — | — | US | disclosed |
| EP-1355919-B1 | MOLECULES WITH EXTENDED HALF-LIVES, COMPOSITIONS AND USES THEREOF | MEDIMMUNE LLC (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20090156563-A1 | Glucan Compositions | CIBA CORP. | 2009-06-18 | — | — | US | disclosed |
| EP-1957168-A2 | GLUCAN COMPOSITIONS | Ciba Holding Inc. (CH) | 2008-08-20 | — | — | EP | disclosed |
| US-20070269458-A1 | Vaccines Against Japanese Encephalitis Virus and West Nile Virus | ACAMBIS INC. (US) | 2007-11-22 | — | — | US | disclosed |
| WO-2007062995-A2 | GLUCAN COMPOSITIONS | CIBA HOLDING INC. (CH) | 2007-06-07 | — | — | WO | disclosed |
| EP-0036420-B1 | PEPTIDES HAVING IMUNOSTIMULATING PROPERTIES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | INSTITUT PASTEUR (FR) | 1983-08-10 | — | — | EP | disclosed |
| EP-0036420-A1 | PEPTIDES HAVING IMUNOSTIMULATING PROPERTIES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | PASTEUR INSTITUT (FR) | 1981-09-30 | — | — | EP | disclosed |
| WO-1981000847-A1 | PEPTIDES HAVING IMUNOSTIMULATING PROPERTIES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PASTEUR INSTITUT (FR) | 1981-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156563-A1 | Glucan Compositions | SORD, GLA, CUTA | SLC7A5 4765/4885ALPI 250/4885PKM 1047/4885 |
| US-20130344101-A1 | B7-1-PE40KDEL EXOTOXIN FUSION GENE-BASED DNA VACCINE AND THE USE THEREOF | PA2G4, PDCD1LG2, MPEG1 | SLC7A5 4519/4885ALPI 2815/4885PKM 1984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.